TheraRadar
← Back
Data updated: Jul 17, 2026

ANTRIM PHARMS LLC

Generics
Pharmaceuticals

ANTRIM PHARMS LLC is a generic drug manufacturer with 1 FDA-approved products.

2015
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

ANTRIM PHARMS LLC's Key Drugs

ANTRIM PHARMS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

ANTRIM PHARMS LLC's Recent FDA Approvals

New NDA/BLA approvals for ANTRIM PHARMS LLC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

ANTRIM PHARMS LLC's Therapeutic Areas

Disease areas where ANTRIM PHARMS LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

ANTRIM PHARMS LLC Pipeline Snapshot

Active clinical trials for ANTRIM PHARMS LLC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Active trial monitoring
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling